BMC Medical Genetics (Nov 2012)

Association of soluble endothelial protein C receptor plasma levels and <it>PROCR</it> rs867186 with cardiovascular risk factors and cardiovascular events in coronary artery disease patients: The Athero <it>Gene</it> Study

  • Kallel Choumous,
  • Cohen William,
  • Saut Noémie,
  • Blankenberg Stefan,
  • Schnabel Renate,
  • Rupprecht Hans J,
  • Bickel Christoph,
  • Munzel Thomas,
  • Tregouet David-Alexandre,
  • Morange Pierre-Emmanuel

DOI
https://doi.org/10.1186/1471-2350-13-103
Journal volume & issue
Vol. 13, no. 1
p. 103

Abstract

Read online

Abstract Background Blood coagulation is an essential determinant of coronary artery disease (CAD). Soluble Endothelial Protein C Receptor (sEPCR) may be a biomarker of a hypercoagulable state. We prospectively investigated the relationship between plasma sEPCR levels and the risk of cardiovascular events (CVE). Methods We measured baseline sEPCR levels in 1673 individuals with CAD (521 with acute coronary syndrome [ACS] and 1152 with stable angina pectoris [SAP]) from the AtheroGene cohort. During a median follow up of 3.7 years, 136 individuals had a CVE. In addition, 891 of these CAD patients were genotyped for the PROCR rs867186 (Ser219Gly) variant. Results At baseline, sEPCR levels were similar in individuals with ACS and SAP (median: 111 vs. 115 ng/mL respectively; p=0.20). Increased sEPCR levels were found to be associated with several cardiovascular risk factors including gender (p=0.006), soluble Tissue Factor levels (p=0.0001), diabetes (p=0.0005), and factors reflecting impaired renal function such as creatinine and cystatin C (p-200) but did not associate with CVE risk. Conclusion Our findings show that in patients with CAD, circulating sEPCR levels are related to classical cardiovascular risk factors and renal impairment but are not related to long-term incidence of CVE.

Keywords